Biomarkers and Personalized Medicine
12.2K views | +0 today
Follow
Biomarkers and Personalized Medicine
Sharing relevant articles on advancements in personalized medicine
Curated by Brian Shields
Your new post is loading...
Your new post is loading...
Scooped by Brian Shields
Scoop.it!

Pfizer's Xalkori And The Progress In Lung Cancer Drugs

Pfizer's Xalkori And The Progress In Lung Cancer Drugs | Biomarkers and Personalized Medicine | Scoop.it
Lung cancer is a tricky disease and there is a graveyard littered with lung cancer drugs that failed in clinical trial.Targeted approaches like Xalkori from Pfizer (PFE) and Tarceva from Roche (RHHBY.OB) work for small segmen...
Brian Shields's insight:

Very good insight on the current targeted options available for lung cancer patients and the promising products in development such as Dacomitinib and Reolysin.  The article notes that the molecular testing rate in Lung Cancer is now 60%, a growth from 10% at the launch of Xalkori.

more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Dr. Kris on Dacomitinib in EGFR-Positive Lung Cancer

Dr. Kris on Dacomitinib in EGFR-Positive Lung Cancer | Biomarkers and Personalized Medicine | Scoop.it
Mark G. Kris, MD, from Memorial Sloan-Kettering Cancer Center, discusses the administration of dacomitinib for patient with EGFR-positive lung cancer.
Brian Shields's insight:

Very Positive data for patients in need of new treatments due to TKI resistance

more...
No comment yet.